Effectiveness of nutritional supplements on cognitive functioning in elderly persons: A systematic review

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 10, 2004, Pages 1041-1049

  Manders, Marleen ^a   De Groot, Lisette C P G M ^a   Van Staveren, Wija A ^a   Wouters Wesseling, Wendeline ^b   Mulders, Ans J M J ^c   Schols, Jos M G A ^d,e   Hoefnagels, Willibrord H L ^f  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NUMICO RESEARCH   (Netherlands)

^c Nursing Home De Landrijt   (Netherlands)

^d De Riethorst   (Netherlands)

^e TILBURG UNIVERSITY   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FATTY ACID; FOLIC ACID; OLIVE OIL; PYRIDOXINE;

AGING; CLINICAL TRIAL; COGNITION; DIET SUPPLEMENTATION; FISH; FOOD COMPOSITION; HUMAN; MEDLINE; METHODOLOGY; NUTRITION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

EID: 7444235321     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.10.m1041     Document Type: Review

References (36)

1. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983;249:2917-2921.
2. Riggs KM, Spiro A, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996;63:306-314.
3. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71:614S-620S.
4. Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr. 2001;86:313-321.
5. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr. 1997;65:20-29.
6. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr. 2000;71:993-998.
7. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54:1265-1272.
8. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalarnin replacement: report of a pilot study. J Am Geriatr Soc. 1992;40:168-172.
9. Jorissen BL, Riedel WJ. Nutrients, age and cognition. Clin Nutr. 2002; 21:89-95.
10. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235-1241.
11. Hogarth MB, Marshall P, Lovat LB, et al. Nutritional supplementation in elderly medical in-patients: a double-blind placebo-controlled trial. Age Ageing. 1996;25:453-457.
12. Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr. 2002;132:1345-1356.
13. de Jong N, Chin A Paw MJ, de Groot LC, et al. Nutrient-dense foods and exercise in frail elderly: effects on B vitamins, homocysteine, methylmalonic acid, and neuropsychological functioning. Am J Clin Nutr. 2001;73:338-346.
14. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition. 2001;17:709-712.
15. Galduroz JC, Carlini EA. The effects of long-term administration of guarana on the cognition of normal, elderly volunteers. Rev Paul Med. 1996;114:1073-1078.
16. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216-1222.
17. Nolan KA, Black RS, Sheu KF, Langberg J, Blass JP. A trial of thiamine in Alzheimer's disease. Arch Neurol. 1991;48:81-83.
18. Seal EC, Metz J, Flicker L, Melny J. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc. 2002;50:146-151.
19. Barak Y, Levine J, Glasman A, Elizur A, Belmaker RH. Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20:729-735.
20. Meador K, Loring D, Nichols M, et al. Preliminary findings of high-dose thiamine in dementia of Alzheimer's type. J Geriatr Psychiatry Neurol. 1993;6:222-229.
21. Deijen JB, van der Beek EJ, Orlebeke JF, van den Berg H. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berlin). 1992;109:489-496.
22. Herrmann WM, Dietrich B, Hiersemenzel R. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance - acetyl-L-carnitine - in patients with organic brain syndrome. Int J Clin Pharmacol Res. 1990;10:81-84.
23. Thal LJ, Calvani M, Amato A, Carta A. A 1-year controlled trial of acetyl-1-carnitine in early-onset AD. Neurology. 2000;55:805-810.
24. Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 1996;47:705-711.
25. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocamitine in patients with Alzheimer's disease. Arch Neurol. 1992;49:1137-1141.
26. Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 1991;41:1726-1732.
27. Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN. Double-blind, placebo controlled study of acetyl-1-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin. 1990;11:638-647.
28. Arrigo A, Casale R, Buonocore M, Ciano C. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency. Int J Clin Pharmacol Res. 1990;10:133-137.
29. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol. 1986;24:511-516.
30. Martin A, Youdim K, Szprengiel A, Shukitt-Hale B, Joseph J. Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. Nutr Rev. 2002;60:308-326.
31. Calvaresi E, Bryan J. B vitamins, cognition, and aging: a review. J Gerontol B Psychol Sci Soc Sci. 2001;56:327-339.
32. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol. 1997;145:33-41.
33. Solfrizzi V, Panza F, Torres F, et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology. 1999;52:1563-1569.
34. Huijbregts PP, Feskens EJ, Rasanen L, et al. Dietary patterns and cognitive function in elderly men in Finland, Italy and The Netherlands. Eur J Clin Nutr. 1998;52:826-831.
35. Brooks JO, Yesavage JA, Carta A, Bravi D. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int Psychogeriatr. 1998;10:193-203.
36. Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L, Senin U. Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res. 1990;10:75-79.